Product Code: GVR-4-68039-608-0
Endometrial Ablation Market Growth & Trends:
The global endometrial ablation market size is estimated to reach USD 1.70 billion by 2030, expanding at a CAGR of 5.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the growing prevalence of gynecological disorders and public awareness about endometrial ablation procedures. According to the Endocrine Society, PCOS affects between 7% and 10% of all women of reproductive age and is the foremost cause of infertility, which will certainly contribute to the overall market growth. Furthermore, the increased emphasis on raising awareness of gynecological cancer and the increasing prevalence of adenomyosis in women, especially after the age of 50 years, will have a positive impact on endometrial ablation surgery worldwide.
As per the United Nations ESCAP, out of the total population, around 53.2% of the population aged 60 years and above were women, and around 61.2% of the population aged 80 years and more were women in 2020. Thus, the rise in the geriatric women population also contributes to the market growth. Despite these favorable growth environments, the potential complications connected with uterine ablation surgery, like uterine perforation, high fever, and shortness of breath, may slightly impede market dynamics. Moreover, it has become possible to destroy the endometrium in situ in a day-care procedure due to the availability of minimally invasive endometrial ablation procedures as an alternative to surgeries. This procedure is less risky and technically simple to perform.
According to the International Federation of Gynecology and Obstetrics (FIGO), Abnormal Uterine Bleeding (AUB) in the reproductive years has a significant global impact, with an incidence of around 3 to 30% among reproductive-aged women. Thereby expected to propel the growth of the overall market. The global market players are undertaking various initiatives, such as organizing social media campaigns and launching websites to raise awareness about women-associated diseases, such as the AUB. This strategy enables companies to increase their capabilities, improve their competencies, and expand their product portfolios. For instance, in August 2022, Minerva Surgical, Inc. launched a "Time to Talk" social media campaign and local event series. This initiative will help raise awareness about AUB worldwide. This initiative will increase the consumer base for endometrial ablation devices, driving revenue generation.
Endometrial Ablation Market Report Highlights:
- The radiofrequency ablation segment dominated the global endometrial ablation industry and accounted for the largest revenue share of 56.0% in 2024.
- In 2024, the clinics segment dominated the market owing to the increased preference for clinics over hospitals to perform endometrial ablation procedures.
- North America held the largest share in 2024 owing to the rising cases of gynecological disorders, improvement in healthcare infrastructure, and a strong foundation of top industry players to deliver cutting-edge endometrial ablation devices.
- Market players adopt various strategies to increase the reach of their products in the market and improve availability in diverse geographic areas.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Endometrial Ablation Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. Endometrial Ablation Market: Product Business Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Product Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Cryoablation
- 4.4.1. Cryoablation Market, 2018 - 2030 (USD Million)
- 4.5. Radiofrequency Ablation
- 4.5.1. Radiofrequency Ablation Market, 2018 - 2030 (USD Million)
- 4.6. Hydrothermal Ablation
- 4.6.1. Hydrothermal Ablation Market, 2018 - 2030 (USD Million)
- 4.7. Thermal Balloon
- 4.7.1. Thermal Balloon Market, 2018 - 2030 (USD Million)
- 4.8. Microwave Energy
- 4.8.1. Microwave Energy Market, 2018 - 2030 (USD Million)
- 4.9. Others
- 4.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Endometrial Ablation Market: End Use Business Analysis
- 5.1. End Use Market Share, 2024 & 2030
- 5.2. End Use Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
- 5.5. Clinics
- 5.5.1. Clinics Market, 2018 - 2030 (USD Million)
- 5.6. Ambulatory Centers
- 5.6.1. Ambulatory Centers Market, 2018 - 2030 (USD Million)
Chapter 6. Endometrial Ablation Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2024 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.4. North America
- 6.4.1. North America Endometrial Ablation Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.4.2. U.S.
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Regulatory Framework
- 6.4.2.3. Competitive Insights
- 6.4.2.4. U.S. Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Canada
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Regulatory Framework
- 6.4.3.3. Competitive Insights
- 6.4.3.4. Canada Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. Mexico
- 6.4.4.1. Key Country Dynamics
- 6.4.4.2. Regulatory Framework
- 6.4.4.3. Competitive Insights
- 6.4.4.4. Mexico Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Europe
- 6.5.1. Europe Endometrial Ablation Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.5.2. UK
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Regulatory Framework
- 6.5.2.3. Competitive Insights
- 6.5.2.4. UK Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Germany
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Regulatory Framework
- 6.5.3.3. Competitive Insights
- 6.5.3.4. Germany Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.4. France
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Regulatory Framework
- 6.5.4.3. Competitive Insights
- 6.5.4.4. France Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.5. Italy
- 6.5.5.1. Key Country Dynamics
- 6.5.5.2. Regulatory Framework
- 6.5.5.3. Competitive Insights
- 6.5.5.4. Italy Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.6. Spain
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Regulatory Framework
- 6.5.6.3. Competitive Insights
- 6.5.6.4. Spain Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.7. Sweden
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Regulatory Framework
- 6.5.7.3. Competitive Insights
- 6.5.7.4. Sweden Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.8. Norway
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Regulatory Framework
- 6.5.8.3. Competitive Insights
- 6.5.8.4. Norway Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.9. Denmark
- 6.5.9.1. Key Country Dynamics
- 6.5.9.2. Regulatory Framework
- 6.5.9.3. Competitive Insights
- 6.5.9.4. Denmark Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Asia Pacific Endometrial Ablation Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.6.2. Japan
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Regulatory Framework
- 6.6.2.3. Competitive Insights
- 6.6.2.4. Japan Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. China
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Regulatory Framework
- 6.6.3.3. Competitive Insights
- 6.6.3.4. China Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. India
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Regulatory Framework
- 6.6.4.3. Competitive Insights
- 6.6.4.4. India Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Thailand
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Regulatory Framework
- 6.6.5.3. Competitive Insights
- 6.6.5.4. Thailand Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.6. Australia
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Regulatory Framework
- 6.6.6.3. Competitive Insights
- 6.6.6.4. Australia Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.7. South Korea
- 6.6.7.1. Key Country Dynamics
- 6.6.7.2. Regulatory Framework
- 6.6.7.3. Competitive Insights
- 6.6.7.4. South Korea Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Latin America
- 6.7.1. Latin America Endometrial Ablation Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.7.2. Brazil
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Regulatory Framework
- 6.7.2.3. Competitive Insights
- 6.7.2.4. Brazil Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7.3. Argentina
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Regulatory Framework
- 6.7.3.3. Competitive Insights
- 6.7.3.4. Argentina Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. MEA
- 6.8.1. MEA Endometrial Ablation Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 6.8.2. South Africa
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Regulatory Framework
- 6.8.2.3. Competitive Insights
- 6.8.2.4. South Africa Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Regulatory Framework
- 6.8.3.3. Competitive Insights
- 6.8.3.4. Saudi Arabia Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.4. UAE
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Regulatory Framework
- 6.8.4.3. Competitive Insights
- 6.8.4.4. UAE Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.5. Kuwait
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Regulatory Framework
- 6.8.5.3. Competitive Insights
- 6.8.5.4. Kuwait Endometrial Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Participant Overview
- 7.2. Company Market Position Analysis
- 7.3. Company Categorization
- 7.4. Strategy Mapping
- 7.5. Company Profiles/Listing
- 7.5.1. Medtronic
- 7.5.1.1. Overview
- 7.5.1.2. Financial Performance
- 7.5.1.3. Product Benchmarking
- 7.5.1.4. Strategic Initiatives
- 7.5.2. The Cooper Companies, Inc.
- 7.5.2.1. Overview
- 7.5.2.2. Financial Performance
- 7.5.2.3. Product Benchmarking
- 7.5.2.4. Strategic Initiatives
- 7.5.3. Boston Scientific Corporation
- 7.5.3.1. Overview
- 7.5.3.2. Financial Performance
- 7.5.3.3. Product Benchmarking
- 7.5.3.4. Strategic Initiatives
- 7.5.4. Johnson & Johnson Service Inc.
- 7.5.4.1. Overview
- 7.5.4.2. Financial Performance
- 7.5.4.3. Product Benchmarking
- 7.5.4.4. Strategic Initiatives
- 7.5.5. Olympus Corporation
- 7.5.5.1. Overview
- 7.5.5.2. Financial Performance
- 7.5.5.3. Product Benchmarking
- 7.5.5.4. Strategic Initiatives
- 7.5.6. Richard Wolf GmbH
- 7.5.6.1. Overview
- 7.5.6.2. Financial Performance
- 7.5.6.3. Product Benchmarking
- 7.5.6.4. Strategic Initiatives
- 7.5.7. AngioDynamics
- 7.5.7.1. Overview
- 7.5.7.2. Financial Performance
- 7.5.7.3. Product Benchmarking
- 7.5.7.4. Strategic Initiatives
- 7.5.8. Hologic, Inc.
- 7.5.8.1. Overview
- 7.5.8.2. Financial Performance
- 7.5.8.3. Product Benchmarking
- 7.5.8.4. Strategic Initiatives
- 7.5.9. Minerva Surgical, Inc.
- 7.5.9.1. Overview
- 7.5.9.2. Financial Performance
- 7.5.9.3. Product Benchmarking
- 7.5.9.4. Strategic Initiatives